Cargando…
Herpes zoster and long-term vascular risk: a retrospective cohort study
Herpes zoster (HZ) represents a serious health problem in the general population due to its abundance and complications. Stroke and acute myocardial infarction are well-documented short-term complications of HZ, primarily due to vasculopathy in the cerebral and coronary arteries. However, no major s...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911591/ https://www.ncbi.nlm.nih.gov/pubmed/36759695 http://dx.doi.org/10.1038/s41598-023-29667-w |
_version_ | 1784885019516338176 |
---|---|
author | Horev, Amir Horev, Anat Gordon-Irshai, Adi Gordon, Michal Andre, Nicolas Ifergane, Gal |
author_facet | Horev, Amir Horev, Anat Gordon-Irshai, Adi Gordon, Michal Andre, Nicolas Ifergane, Gal |
author_sort | Horev, Amir |
collection | PubMed |
description | Herpes zoster (HZ) represents a serious health problem in the general population due to its abundance and complications. Stroke and acute myocardial infarction are well-documented short-term complications of HZ, primarily due to vasculopathy in the cerebral and coronary arteries. However, no major study to date has specifically demonstrated that HZ is a long-term risk factor for all Major Adverse Cardiac and Cerebrovascular Events (MACCE). A retrospective cohort study was conducted analyzing the association between HZ and MACCE. We compared HZ patients diagnosed between 2001 and 2018 and a matched control group. The model was stratified according to matched pairs and adjusted for age, socioeconomic status, history of dyslipidemia, and prior myocardial infarction (MI). Association between HZ exposure and stroke was assessed through a multivariable Cox regression analysis. The study included 41,930 patients, with 20,965 patients in each group. The risk of MACCE was 19% higher among HZ patients in the first year of follow up (P < 0.001). Antiviral treatment did not positively affect long-term survival among HZ patients (P < 0.001). These results suggest that HZ is a marker of long-term vascular risk. Additional studies will be needed to further evaluate this risk, the impact of HZ vaccination on such risk, and potential mitigation strategies. |
format | Online Article Text |
id | pubmed-9911591 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-99115912023-02-11 Herpes zoster and long-term vascular risk: a retrospective cohort study Horev, Amir Horev, Anat Gordon-Irshai, Adi Gordon, Michal Andre, Nicolas Ifergane, Gal Sci Rep Article Herpes zoster (HZ) represents a serious health problem in the general population due to its abundance and complications. Stroke and acute myocardial infarction are well-documented short-term complications of HZ, primarily due to vasculopathy in the cerebral and coronary arteries. However, no major study to date has specifically demonstrated that HZ is a long-term risk factor for all Major Adverse Cardiac and Cerebrovascular Events (MACCE). A retrospective cohort study was conducted analyzing the association between HZ and MACCE. We compared HZ patients diagnosed between 2001 and 2018 and a matched control group. The model was stratified according to matched pairs and adjusted for age, socioeconomic status, history of dyslipidemia, and prior myocardial infarction (MI). Association between HZ exposure and stroke was assessed through a multivariable Cox regression analysis. The study included 41,930 patients, with 20,965 patients in each group. The risk of MACCE was 19% higher among HZ patients in the first year of follow up (P < 0.001). Antiviral treatment did not positively affect long-term survival among HZ patients (P < 0.001). These results suggest that HZ is a marker of long-term vascular risk. Additional studies will be needed to further evaluate this risk, the impact of HZ vaccination on such risk, and potential mitigation strategies. Nature Publishing Group UK 2023-02-09 /pmc/articles/PMC9911591/ /pubmed/36759695 http://dx.doi.org/10.1038/s41598-023-29667-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Horev, Amir Horev, Anat Gordon-Irshai, Adi Gordon, Michal Andre, Nicolas Ifergane, Gal Herpes zoster and long-term vascular risk: a retrospective cohort study |
title | Herpes zoster and long-term vascular risk: a retrospective cohort study |
title_full | Herpes zoster and long-term vascular risk: a retrospective cohort study |
title_fullStr | Herpes zoster and long-term vascular risk: a retrospective cohort study |
title_full_unstemmed | Herpes zoster and long-term vascular risk: a retrospective cohort study |
title_short | Herpes zoster and long-term vascular risk: a retrospective cohort study |
title_sort | herpes zoster and long-term vascular risk: a retrospective cohort study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911591/ https://www.ncbi.nlm.nih.gov/pubmed/36759695 http://dx.doi.org/10.1038/s41598-023-29667-w |
work_keys_str_mv | AT horevamir herpeszosterandlongtermvascularriskaretrospectivecohortstudy AT horevanat herpeszosterandlongtermvascularriskaretrospectivecohortstudy AT gordonirshaiadi herpeszosterandlongtermvascularriskaretrospectivecohortstudy AT gordonmichal herpeszosterandlongtermvascularriskaretrospectivecohortstudy AT andrenicolas herpeszosterandlongtermvascularriskaretrospectivecohortstudy AT iferganegal herpeszosterandlongtermvascularriskaretrospectivecohortstudy |